MedPath

Pulse Wave Analysis in Advanced Heart Failure

Withdrawn
Conditions
Left Ventricular Assist Device
Heart Failure
Intra-aortic Balloon Pump
LVAD-related GI Bleed
LVAD Clot
Registration Number
NCT01642927
Lead Sponsor
University of Minnesota
Brief Summary

A comparison of pulse wave characteristics, as measured by peripheral tonometry, in pre and post Left Ventricular Assist Device (LVAD) patients.

Detailed Description

Pulse waveforms, especially central pressure waveforms, are predictive of cardiovascular events. Peripheral waveforms have been correlated to central waveforms. Peripheral waveforms can be easily measured through applanation tonometry. In this study the investigators hypothesize:

1. That previously established peripheral tonometry techniques would apply to patients with advanced heart failure, including continuous flow LVADs and facilitate serial evaluation of central hemodynamics without invasive monitoring.

2. That temporary changes in LVAD speed will be evident in frequency spectrum analysis of peripheral, non-invasive waveforms.

3. That clinical events involving LVAD will have characteristic frequency spectra.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1)18 years of age or older

2)Advanced heart failure as defined by need for IABP or LVAD

3)One or more of the following:

  • Current inpatient heart failure treatment with intra-aortic balloon pump (IABP)-IABP Group

    •≤ 1 week post-LVAD implantation with current IABP support-IABP/LVAD Group

    •≥ 3 mo post-LVAD placement and scheduled for LVAD speed optimization with echocardiography.-Post-LVAD Group

  • Post-LVAD placement with suspected GI hemorrhage or LVAD thrombosis-LVAD Event Group

    4)Voluntary written informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care.

Read More
Exclusion Criteria
  1. Clinical status will not permit pause of IABP (IABP and IABP/LVAD Groups)
  2. Unable to undergo echo or oversewn or patched aortic valve (Post-LVAD Group)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Observation of pulse wave signatures in LVAD patientsongoing
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Univeristy of Minnesota Lillehei Heart Institute

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath